ArticleOncotarget2016

PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells.

Xin-Min Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.